Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical cord blood serum eye drops for severe dry eye
IRCT20230925059512N1Phase 2Completed
- Sponsor
- Baqiyatallah University of Medical Sciences
- Start
- Aug 2024
- Modality
- Stem Cell Therapies → Cell Therapies, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of human umbilical cord blood serum in dry eye syndrome (DED), Sjögren's syndrome and Eye injury (2 arms), sponsored by Baqiyatallah University of Medical Sciences. Primary endpoints: Subjective symptoms of dry eyes, Visual acuity and 4 more. Started Aug 2024; status: completed.
02
Drugs
human umbilical cord blood serum
03
Conditions
dry eye syndrome (DED)Sjögren's syndromeEye injury
Beyond the preview
Go deeper on IRCT20230925059512N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230925059512N1.